Compare Abeona Therapeutics Inc (ABEO) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Becton Dickinson and Co — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co is far larger — about 117.3× Abeona Therapeutics Inc's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | BDX | |
|---|---|---|
Market Cap | $421.19M | $49.41B |
Sector | Health | Health |
52-Week High | $7.45 | $185.39 |
52-Week Low | $4.17 | $138.62 |
Enterprise Value | $276.10M | $65.51B |
Dividend Yield | — | 2.32% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
